June 1920 |
Established Teikoku Hormone Research Institute in Minami Yoshidamachi, Yokohama |
June 1929 |
Changed the company to a stock organization and changed the company name to Teikoku Hormone Mfg. Research Laboratory Co., Ltd. |
January 1936 |
Newly established the Takatsu Factory (the Kawasaki Research Center) in Takatsu-cho, Tachibana-gun, Kanagawa (currently Shimosakunobe, Takatsu-ku, Kawasaki-shi) |
October 1945 |
Moved the head office to Shimosakunobe, Kawasaki-shi (on the premises of Takatsu Factory) and changed the company name to Teikoku Hormone Mfg. Co., Ltd. |
October 1946 |
Relocated the head office to Shiba Minamisakuma-cho, Minato-ku, Tokyo |
June 1949 |
Opened a branch office in Osaka |
September 1955 |
Listed on the Tokyo Stock Exchange |
May 1957 |
Opened a branch office in Fukuoka |
July 1957 |
Opened a branch office in Nagoya |
June 1958 |
Opened a branch office in Sapporo |
August 1962 |
Opened a branch office in Tokyo |
November 1962 |
Relocated the head office to 5-1, Akasaka 2-chome, Minato-ku, Tokyo |
June 1967 |
Opened a branch office in Sendai and Hiroshima |
June 1969 |
Completed construction of a new research building on the premises of the Kawasaki Research Center |
June 1970 |
Opened a branch office in Yokohama |
April 1980 |
Established the Iwaki Factory |
April 1987 |
Opened a branch office in Kyoto |
May 1991 |
Established Medical System Service Kanagawa, Inc. (currently ASKA Pharma Medical Co., Ltd.) (consolidated subsidiary) |
September 1993 |
Listed on the First Section of the Tokyo Stock Exchange |
April 1997 |
Opened the International Representative Office in Frankfurt |
September 2001 |
Relocated the head office to 5-1, Shibaura 2-chome, Minato-ku, Tokyo |
February 2005 |
Approved merger agreement with Grelan Pharmaceutical Co., Ltd. |
October 2005 |
Merged with Grelan Pharmaceutical Co., Ltd. and changed the trade name to ASKA Pharmaceutical Co., Ltd. |
April 2009 |
Established Actavis ASKA Co., Ltd. |
June 2013 |
Established ASKA Animal Health Co., Ltd. |
April 2017 |
Merged with Actavis ASKA Co., Ltd. |
October 2018 |
Invested in NeoASKA Pharma Private Limited in India jointly with Omnicare Drugs India Private Limited |
April 2020 |
Moved the Kawasaki Research Center (Kawasaki-shi, Kanagawa) to the Shonan Research Center (Fujisawa-shi, Kanagawa) |
January 2021 |
Invested in Ha Tay Pharmaceutical Joint Stock Company in Vietnam (an associate accounted for using equity method) |
April 2021 |
ASKA Pharmaceutical Co., Ltd. established the Company through a sole-share transfer, and the Company's shares were listed on the First Section of the Tokyo Stock Exchange (ASKA Pharmaceutical Co., Ltd. was delisted in March 2021).
Acquired all shares of ASKA Animal Health Co., Ltd. and ASKA Pharma Medical Co., Ltd. held by ASKA Pharmaceutical Co., Ltd. through dividend in kind and made them direct subsidiaries of ASKA Pharmaceutical Co., Ltd. |
April 2021 |
Invested in JAPAN GLASS INDUSTRY CO., LTD. (an associate accounted for using equity method) |
April 2021 |
Established London Office |
April 2022 |
Moved from the First Section of the Tokyo Stock Exchange to the Prime Market due to a revision of the Tokyo Stock Exchange's market classification. |